Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Jiangsu Hengrui Medicine Co., Ltd.
  6. Financials
    600276   CNE0000014W7

JIANGSU HENGRUI MEDICINE CO., LTD.

(600276)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 194 230385 431591 745326 910--
Entreprise Value (EV)1 190 340380 387580 941308 066304 485297 606
P/E ratio 48,0x72,9x93,7x51,3x40,6x33,6x
Yield 0,42%0,26%0,18%0,34%0,40%0,49%
Capitalization / Revenue 11,2x16,6x21,3x11,4x9,38x7,95x
EV / Revenue 10,9x16,3x20,9x10,8x8,74x7,24x
EV / EBITDA 38,3x56,0x77,6x43,5x35,3x28,5x
Price to Book 9,85x15,6x19,5x8,78x7,43x6,23x
Nbr of stocks (in thousands) 6 362 6296 341 6386 370 8466 372 511--
Reference price (CNY) 30,560,892,951,351,351,3
Announcement Date 02/15/201903/22/202004/19/2021---
1 CNY in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 17 41823 28927 73528 65034 85241 106
EBITDA1 4 9766 7967 4837 0818 63710 457
Operating profit (EBIT)1 4 5976 1507 0076 7588 44810 218
Operating Margin 26,4%26,4%25,3%23,6%24,2%24,9%
Pre-Tax Profit (EBT)1 4 4996 0566 8957 0918 89310 825
Net income1 4 0665 3286 3286 3738 0369 751
Net margin 23,3%22,9%22,8%22,2%23,1%23,7%
EPS2 0,640,830,991,001,261,53
Dividend per Share2 0,130,160,170,180,210,25
Announcement Date 02/15/201903/22/202004/19/2021---
1 CNY in Million
2 CNY
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2021 S2 2022 Q1
Net sales1 6 9296 3686 9016 99720 3797 056
EBITDA ------
Operating profit (EBIT)1 -1 4271 8461 7204 7641 886
Operating Margin -22,4%26,7%24,6%23,4%26,7%
Pre-Tax Profit (EBT) ------
Net income ------
Net margin ------
EPS2 0,230,140,240,29-0,28
Dividend per Share ------
Announcement Date 04/19/202108/19/202110/19/2021---
1 CNY in Million
2 CNY
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 3 8905 04410 80518 84422 42529 303
Leverage (Debt / EBITDA) -0,78x-0,74x-1,44x-2,66x-2,60x-2,80x
Free Cash Flow1 2 2493 2572 8814 7595 7748 882
ROE (Net Profit / Equities) 23,6%24,0%22,5%18,9%19,0%19,4%
Shareholders' equity1 17 22722 18228 11433 80142 32850 326
ROA (Net Profit / Asset) 20,1%21,3%20,3%16,0%16,8%17,3%
Assets1 20 20124 95931 14439 94447 76256 507
Book Value Per Share2 3,103,894,775,846,908,24
Cash Flow per Share2 0,440,600,540,881,131,00
Capex1 526560551601696922
Capex / Sales 3,02%2,41%1,99%2,10%2,00%2,24%
Announcement Date 02/15/201903/22/202004/19/2021---
1 CNY in Million
2 CNY
Key data
Capitalization (CNY) 326 909 808 862
Capitalization (USD) 51 202 062 566
Net sales (CNY) 27 734 598 750
Net sales (USD) 4 344 735 833
Number of employees 28 903
Sales / Employee (CNY) 959 575
Sales / Employee (USD) 150 321
Free-Float 47,0%
Free-Float capitalization (CNY) 153 631 221 991
Free-Float capitalization (USD) 24 062 402 617
Avg. Exchange 20 sessions (CNY) 3 206 130 112
Avg. Exchange 20 sessions (USD) 502 253 107
Average Daily Capital Traded 0,98%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA